El Zohour Club
New Cairo, Cairo Governorate, 470001, Egypt
NCT Number: NCT06599190
Fifty female athletes suffering from stress incontinence (SUI) will participate in this study. They will be selected from El Zohour Club, New Cairo City.
Looking for future studies?
Notify Me14 year–18 year
Female
Interventional
Phase 2
New Cairo, Cairo Governorate, 470001, Egypt
They will be randomly distributed into 2 groups equal in numbers:
Group (A) (Control group) consists of 25 female athletes. They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.
Group (B) (Study group) consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.
Before data collection, the purpose and procedures will be fully explained to the females. Informed consent will be obtained from each female. Each female will be evaluated following a standard protocol.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The female athlete will be excluded if they had:
They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.
consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.
Time frame: 24 hours pad test for12 weeks
Pad testing will be used to quantify the volume of urine loss by weighing an absorbent pad before and after some type of leakage provocation. The test will start with weighting clean empty pad in grams. Then, it will be used until next time and weighted again. The weight of the used pad will be subtracted from the weight of the empty pad so the net result will determine the amount of leakage.
Time frame: 12 weeks
The measurements will be taken in crock-lying position with a full bladder, neutral lumbar spine. The ultrasound transducer will be inserted transversely directly superior to the symphysis pubis, probe is tilted 60 degrees from vertical (Arab, 2010). Every female will perform 3 maximal PFM contractions so that displacement of the bladder wall, because of a PFM contraction, could be measured.
Time frame: 12 weeks
The ICIQ-SF will be used in assessment of each female in both groups. It is used to measure severity and impact of UI on the quality of life in women. The ICIQ-SF is formed of six items of which four main items ask for rating of UI symptoms in the past 4 weeks. A score of zero means no leakage of urine and no affection on quality of life. (Question 1): quantifies the frequency of urinary leaking, (question 2): evaluates the amount of leaking and (question 3): how much the urinary incontinence interferes with everyday life (Hilton and Robinson, 2011). The scores for items 3, 4 and 5 are taken for the final ICIQ-SF score. Items 1 and 2 are demographic and the final item is a self-diagnostic item for the type of UI. ICIQ- SF (range 0-21) is given four scoring categories: slight (1-5), moderate (6-12), severe (13-18) and very severe (19-21).
Badr University
Other
Effect Of Abdominal Hypopressive Training On Stress Urinary IncontinenceIn Female Athletes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07530484
Female Stress Urinary Incontinence, Female Urogenital Diseases
Taipei, Taiwan
View Trial DetailsNCT05534269
Female Stress Urinary Incontinence, Female Urogenital Diseases
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT01032265
Female Stress Urinary Incontinence, Female Urogenital Diseases
Umeå, Sweden
View Trial DetailsNCT01848938
Female Stress Urinary Incontinence, Female Urogenital Diseases
Umeå, Sweden
View Trial Details